๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography

โœ Scribed by Zander, T.; Scheffler, M.; Nogova, L.; Kobe, C.; Engel-Riedel, W.; Hellmich, M.; Papachristou, I.; Toepelt, K.; Draube, A.; Heukamp, L.; Buettner, R.; Ko, Y. D.; Ullrich, R. T.; Smit, E.; Boellaard, R.; Lammertsma, A. A.; Hallek, M.; Jacobs, A. H.; Schlesinger, A.; Schulte, K.; Querings, S.; Stoelben, E.; Neumaier, B.; Thomas, R. K.; Dietlein, M.; Wolf, J.


Book ID
117990412
Publisher
American Society of Clinical Oncology
Year
2011
Tongue
English
Weight
189 KB
Volume
29
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Evaluation of chemotherapy response in p
โœ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m